AVXL- Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL) has 3 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. AVXL is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 125.0K | $321.9K | - | |
| Dir | 55.0K | $141.6K | - | |
| Other | 12.5K | $32.2K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Donhauser Peter D.O.49 | Director | Buy | 2,835 | $3.64 | $10,319.40 | +130.9% | +38.2% | +113.0% | |
| May 15, 2024 | Thomas Steffen | Director | Buy | 5,000 | $4.52 | $22,600.00 | New | +43.0% | +86.4% | |
| Mar 28, 2024 | Missling Christopher U61 | President And CEO | Sale+OE | 73,380 | $5.11 | $374,971.80 | -5.5% | -25.0% | +71.3% | |
| Jun 28, 2023 | Missling Christopher U61 | President And CEO | Sale+OE | 268,000 | $7.98 | $2,139,310.00 | -20.8% | -14.8% | -46.2% | |
| May 25, 2022 | Skarpelos Athanasios | Director | Sale+OE | 50,000 | $9.06 | $453,000.00 | -3.7% | +11.6% | -1.5% | |
| Jun 29, 2021 | Missling Christopher U61 | President And CEO | Sale+OE | 51,620 | $26.00 | $1,342,120.00 | -4.8% | -18.6% | -58.1% | |
| Jun 29, 2021 | Boenisch Sandra | Pfo And Treasurer | Sale+OE | 166,696 | $26.53 | $4,422,444.88 | -87.9% | -18.6% | -58.1% | |
| May 21, 2021 | Favus Elliot | Director | Sale+OE | 145,000 | $11.70 | $1,696,282.50 | -100% | +56.6% | -17.6% | |
| May 17, 2021 | Donhauser Peter D.O.49 | Director | Buy | 1,000 | $10.93 | $10,930.00 | +85.8% | +68.4% | -16.4% | |
| Feb 24, 2021 | Favus Elliot | Director | Sale+OE | 145,500 | $12.66 | $1,841,855.40 | -100% | -10.2% | -14.1% |
Page 1Next →